Long-Term Follow up of a Randomized Phase 2 Study of Low-Dose Decitabine Versus Low-Dose Azacitidine in Lower-Risk Myelodysplastic Syndromes, Guillermo Montalban-Bravo, Elias Jabbour, Caleb Class, Nicholas Short, Rashmi Kanagal-Shamanna, Tapan Kadia, Gautam Borthakur, Naveen Pemmaraju, Koji Sasaki, Zeev Estrov, Jorge Cortes, Farhad Ravandi, Yesid Alvarado, Rami Komrokji, Mikkael Sekeres, David Steensma, Amy DeZern, Gail Roboz, Hui Yang, Hagop Kantarjian, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS